UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031004 |
|---|---|
| Receipt number | R000034972 |
| Scientific Title | Phase 2 study of gemcitabine and docetaxel chemotherapy for advanced bone and soft tissue sarcomas |
| Date of disclosure of the study information | 2018/03/01 |
| Last modified on | 2023/01/30 12:10:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/01/25 19:42:50 | ||
| 2 | Update | 2018/10/19 12:55:49 | Recruitment status |
|
| 3 | Update | 2020/01/30 16:13:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Research ethics review Organization Organization Address Address Tel Institutions |
|
| 4 | Update | 2020/01/30 16:25:09 | Date of IRB Anticipated trial start date Last follow-up date |
|
| 5 | Update | 2022/01/27 13:33:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
| 6 | Update | 2023/01/30 12:10:00 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
